Nutrition Supplement Pyridoxal 5-Phosphate P5P with Good Price

PLP serves as a coenzyme for more than 140 enzymes, most involved in amino acid metabolism. It participates in transamination, decarboxylation, racemization, deamination, and elimination reactions. In transamination, PLP shuttles amino groups between amino acids and α-keto acids, enabling amino acid synthesis and degradation. In decarboxylation, it assists in producing biogenic amines such as serotonin, dopamine, GABA, and histamine. PLP is also required for the synthesis of heme, sphingolipids, niacin, and certain neurotransmitters. It catalyzes glycogen breakdown, and in the metabolism of sulfur-containing amino acids, including homocysteine. It also supports one-carbon metabolism, nucleic acid synthesis, and polyamine production, and it influences steroid hormone receptor activity and gene expression. Through these reactions, PLP is indispensable for normal nervous system function, immune regulation, and energy metabolism.

In the body, dietary vitamin B6 includes pyridoxine, pyridoxamine, and pyridoxal. These forms are absorbed and converted in the liver and other tissues to PLP by pyridoxal kinase, which phosphorylates them, and by pyridoxine 5′-phosphate oxidase. PLP is tightly regulated because it is reactive. Most PLP is bound to proteins; free PLP is rapidly hydrolyzed by phosphatases to pyridoxal, which can cross membranes and be excreted. The liver is the main site of PLP synthesis and storage, and plasma PLP is a common biomarker of vitamin B6 status.

PLP is involved in many clinical contexts. Deficiency can result from inadequate intake, malabsorption, alcoholism, liver disease, pregnancy, or use of certain drugs such as isoniazid, hydralazine, penicillamine, and cycloserine, which interfere with PLP-dependent enzymes. Symptoms include peripheral neuropathy, seizures, dermatitis, anemia, depression, confusion, and impaired immune function. Because PLP is needed for neurotransmitter synthesis, neurological manifestations are prominent. Severe deficiency in infants can cause irritability and convulsions. Measurement of plasma PLP is useful, but it can be affected by inflammation and alkaline phosphatase. Inborn errors affecting PLP metabolism, transport, or binding can cause severe epilepsy and developmental delay.

Therapeutically, pyridoxine or PLP is used to treat or prevent vitamin B6 deficiency, sideroblastic anemia, some forms of seizures, and complications of isoniazid therapy. Pyridoxine is also used for nausea and vomiting of pregnancy, though high doses can cause sensory neuropathy. PLP itself is not usually given orally because it is poorly absorbed and rapidly dephosphorylated; however, research explores its use in inherited disorders of PLP metabolism, such as pyridoxine-dependent epilepsy and PNPO deficiency. In such conditions, PLP or pyridoxine can dramatically reduce seizures. Doses must be individualized, and monitoring is advised because excessive pyridoxine can lead to irreversible neuropathy.

PLP is light-sensitive and unstable in alkaline solutions; it should be protected from light and stored appropriately in laboratory and clinical settings. Its reactive aldehyde allows it to act as a versatile electron sink, stabilizing carbanionic intermediates during catalysis. This chemical versatility explains why PLP is one of the most ancient and widespread coenzymes in nature. Overall, pyridoxal 5-phosphate is a central metabolic cofactor that links vitamin B6 nutrition to amino acid metabolism, neurotransmitter production, hemoglobin synthesis, and neurological health. Its status should be interpreted alongside clinical findings.